Jul 28, 2015 7:30am EDT Rigel Announces Conference Call and Webcast to Report Second Quarter 2015 Financial Results
Feb 23, 2015 8:03am EST Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor Kinase Inhibitors for Use in Immuno-Oncology Related Indications
